Overview

Safety of Larazotide Acetate in Healthy Volunteers

Status:
Completed
Trial end date:
2006-02-27
Target enrollment:
Participant gender:
Summary
To demonstrate the safety, tolerance and pharmacokinetics of multiple, oral doses of larazotide acetate.
Phase:
Phase 1
Details
Lead Sponsor:
9 Meters Biopharma, Inc.
Alba Therapeutics